Phytopharm PLC
15 October 2002
Phytopharm PLC ( the 'Company')
Notification of Major Interests in Shares
The Company received a notification today from AMVESCAP PLC, informing it that
following a purchase of 500,000 shares on 14 October 2002 , AMVESCAP PLC and
subsidiary companies on behalf of discretionary clients have a non beneficial
interest in 5,610,228 ordinary 1p shares, representing 14.53% of the issued
ordinary share capital of the Company.
The Shares are registered in the following names:
Vidacos Nominees Limited 4,402,834
HSBC Nominees Limited 692,016
Chase Nominees Limited 192,000
Bank of New York Nominees Ltd 179,806
Northern Trust Nominees Limited 85,000
Mellon Bank Pittsburgh Nominees 58,572
In addition the Company received a notification today from AMVESCAP PLC,
informing it that, INVESCO Perpetual Income Fund has an interest in 2,117,072
ordinary 1p shares, representing 5.48% of the issued ordinary share capital of
the Company. The shares are registered in the name of Vidacos Nominees Limited.
15 October, 2002
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.